Video

Innovations in Dermatology: Sarecycline Approved for Acne

Publish date: November 7, 2018
By
Lawrence J. Green, MD
Author and Disclosure Information

The US Food and Drug Administration recently approved sarecycline for the treatment of moderate to severe acne vulgaris. Dr. Lawrence Green reviews clinical trial data on this new oral antibiotic.

 

Vidyard Video

Recommended Reading

Trifarotene cream for acne meets all endpoints in twin phase 3 trials
MDedge Dermatology
Nonablative laser adds benefits to low-dose isotretinoin as treatment for moderate to severe acne
MDedge Dermatology
FDA approves Seysara for treatment of moderate to severe acne
MDedge Dermatology
Mobile App Rankings in Dermatology
MDedge Dermatology
Taurine
MDedge Dermatology
Acne more common in adults with hidradenitis suppurativa
MDedge Dermatology
Innovations in Dermatology: Antibiotic Stewardship in Acne Therapy
MDedge Dermatology
Q and A with Dr. Julie Harper: Treating acne and rosacea
MDedge Dermatology
Topical treatment with retinoid/benzoyl peroxide combination reduced acne scars
MDedge Dermatology
Think barrier repair for acne patients
MDedge Dermatology